Immune Checkpoint Inhibitors and Their Cardiovascular Adverse Effects

Immune checkpoint inhibitors (ICIs) have reshaped and have become a well-established treatment modality for multiple advanced-stage malignancies. ICIs block the immune system regulatory checkpoints, namely CTLA-4 and PD-1/PDL1, which provokes excess immune response against self-antigens. Immune modu...

Descripción completa

Detalles Bibliográficos
Autores principales: Paluri, Ravi Kumar, Pulipati, Yochitha, Regalla, Dileep Kumar Reddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691592/
https://www.ncbi.nlm.nih.gov/pubmed/38045806
http://dx.doi.org/10.3389/or.2023.11456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691592/
https://www.ncbi.nlm.nih.gov/pubmed/38045806
http://dx.doi.org/10.3389/or.2023.11456

Ejemplares similares